Diabetes Care:美国糖尿病患者“三达标率”较高

2013-02-26 Diabetes Care CDS糖尿病在线

  美国学者Sarah Stark Casagrande等报告,2007-2010年间有18.8%的美国糖尿病患者糖化血红蛋白(HbA1c)、血压和低密度脂蛋白胆固醇(LDL-C)水平同时达标,达标率是我国糖尿病患者(5.6%)的3倍以上。研究于2013年2月15日在线发表于《糖尿病护理》(Diabetes Care)杂志。   研究者利用1988-2010年美国国

  美国学者Sarah Stark Casagrande等报告,2007-2010年间有18.8%的美国糖尿病患者糖化血红蛋白(HbA1c)、血压和低密度脂蛋白胆固醇(LDL-C)水平同时达标,达标率是我国糖尿病患者(5.6%)的3倍以上。研究于2013年2月15日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  研究者利用1988-2010年美国国立卫生和营养调查(NHANES)数据,对4926例成年糖尿病患者数据进行了分析。结果显示,2007-2010年美国糖尿病患者HbA1c水平(<7.0%)、血压(<130/80 mm Hg)和LDL-C(<100 mg/dl)达标率依次为52.5%、51.1%和56.2%,3项达标率为18.8%。研究者表示,从1988年到1994年,上述指标的控制情况得到了明显的改善;糖尿病患者中他汀的应用率也从4.2%(1988-1994年)大幅上升至51.4%(2007-2010年)。与非西班牙裔白人相比,墨西哥裔患者HbA1c和LDL-C达标率明显降低,血压和LDL-C达标的非西班牙裔黑人患者较少。与非西班牙裔黑人相比,墨西哥裔患者中HbA1c达标者比例较低。此外,年轻患者中HbA1c和LDL-C达标者的比例较低。

糖尿病相关的拓展阅读:


The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010

OBJECTIVE To determine the prevalence of people with diabetes who meet hemoglobin A1c (A1C), blood pressure (BP), and LDL cholesterol (ABC) recommendations, and their current statin use, factors associated with goal achievement, and changes in the proportion achieving goals between 1988 and 2010.

RESEARCH AND DESIGN METHODS Data were cross-sectional from the National Health and Nutrition Examination Surveys (NHANES) from 1988–1994, 1999–2002, 2003–2006, and 2007–2010. Participants were 4,926 adults aged ≥20 years who self-reported a previous diagnosis of diabetes and completed the household interview and physical examination (n = 1,558 for valid LDL levels). Main outcome measures were A1C, BP, and LDL cholesterol, in accordance with the American Diabetes Association recommendations, and current use of statins.

RESULTS In 2007–2010, 52.5% of people with diabetes achieved A1C <7.0% (<53 mmol/mol), 51.1% achieved BP <130/80 mmHg, 56.2% achieved LDL <100 mg/dL, and 18.8% achieved all three ABCs. These levels of control were significant improvements from 1988 to 1994 (all P < 0.05). Statin use significantly increased between 1988–1994 (4.2%) and 2007–2010 (51.4%, P < 0.01). Compared with non-Hispanic whites, Mexican Americans were less likely to meet A1C and LDL goals (P < 0.03), and non-Hispanic blacks were less likely to meet BP and LDL goals (P < 0.02). Compared with non-Hispanic blacks, Mexican Americans were less likely to meet A1C goals (P < 0.01). Younger individuals were less likely to meet A1C and LDL goals.

CONCLUSIONS Despite significant improvement during the past decade, achieving the ABC goals remains suboptimal among adults with diabetes, particularly in some minority groups. Substantial opportunity exists to further improve diabetes control and, thus, to reduce diabetes-related morbidity and mortality.


    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636628, encodeId=9fc61636628f0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 24 17:38:00 CST 2013, time=2013-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759245, encodeId=9d451e592456d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jun 28 18:38:00 CST 2013, time=2013-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901052, encodeId=e233190105282, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Sep 21 14:38:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473687, encodeId=a72314e3687d9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636628, encodeId=9fc61636628f0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 24 17:38:00 CST 2013, time=2013-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759245, encodeId=9d451e592456d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jun 28 18:38:00 CST 2013, time=2013-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901052, encodeId=e233190105282, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Sep 21 14:38:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473687, encodeId=a72314e3687d9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636628, encodeId=9fc61636628f0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 24 17:38:00 CST 2013, time=2013-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759245, encodeId=9d451e592456d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jun 28 18:38:00 CST 2013, time=2013-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901052, encodeId=e233190105282, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Sep 21 14:38:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473687, encodeId=a72314e3687d9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1636628, encodeId=9fc61636628f0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 24 17:38:00 CST 2013, time=2013-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759245, encodeId=9d451e592456d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Jun 28 18:38:00 CST 2013, time=2013-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901052, encodeId=e233190105282, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Sep 21 14:38:00 CST 2013, time=2013-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473687, encodeId=a72314e3687d9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Feb 28 00:38:00 CST 2013, time=2013-02-28, status=1, ipAttribution=)]

相关资讯

Diabetes Care:LOGIC-Insulin算法指导强化血糖控制效果佳

  来自荷兰鲁汶大学的一项前瞻性、平行组、随机对照临床试验显示,应用计算机软件程序LOGIC-Insulin实施强化血糖控制(TGC)的效能优于经验丰富的护士,且不增加低血糖事件的发生率。该研究2013年2月在线发表在《糖尿病护理》杂志(Diabetes care)上。   对危重患者实施TGC较为困难,且工作强度大,导致血糖控制效果不佳和低血糖发生率增加。LOGIC-Insul

Diabetes Care:经皮氧分压可预测糖尿病患者心血管风险

  意大利学者进行的一项研究提示,经皮氧分压(TcPO2)是无合并症2型糖尿病患者主要不良心脏事件(MACE)风险的潜在预测指标,且预测价值似乎高于踝臂指数(ABI)。研究于2013年2月12日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究入选361例无合并症的2型糖尿病患者,随访45.8个月期间共发生67例MACE。研究者报告,发生MACE的受试者中ABI(≤0.9)

Lancet:糖尿病和肥胖或致巨大儿增多

  一项横断面研究显示,育龄女性糖尿病和肥胖发病率升高与巨大儿出生增多平行相关。论文2013年1月4日在线发表于《柳叶刀》(Lancet)杂志。   研究分析了276436次单胎活产或新发死产,结果表明产妇年龄较大(20~34岁)、身材较高、产次较多、体质指数较高、患糖尿病、过期妊娠及男性胎儿,均与巨大儿发生危险的显著增加相关。巨大儿与因难产和过期妊娠而引发剖宫产,以及孕产妇分娩不良转归的危险增

JGIM:血糖达标非糖尿病患者心血管获益关键

  一项纳入2.6万余例受试者的观察性研究显示,对于2型糖尿病患者,收缩压(SBP,<130 mm Hg)或低密度脂蛋白胆固醇(LDL-C,<100 mg/dl)达标与心血管疾病(CVD)住院风险的降低显著相关,而糖化血红蛋白(HbA1c)达标(<7%)并不是CVD住院风险降低的独立因素。(J Gen Intern Me

PLOS ONE:强化降糖或使肥胖糖尿病患者获益

  一项覆盖9项随机对照研究、59 197例受试者的Meta分析提示,对于体质指数(BMI)>30 kg/m2的糖尿病患者,与标准降糖方案相比,强化降糖方案可有效降低卒中发生风险。(PLoS One. 2013,8:e54465)   在被纳入的59 197例受试者中,2037例罹患卒中。分析结果显示,在整个受试人群中,与标准降糖方案相比,

JAMA Intern Med:普通健康体检未能降低死亡率

  丹麦学者的一项荟萃分析综述表明,普通健康体检未能降低总体死亡率。该综述1月14日在线发表于《JAMA内科学》(JAMA Intern Med)。   此项荟萃分析共纳入14项于1963至1999年间实施的随机对照试验,并评估了年度体检对发病率和死亡率的影响。以仅用于预防咨询和筛查的就诊定义普通体检,排除慢性病治疗或紧急救护所引发的就诊。纳入试验共涉及182,000余例患者